Advertisement

Molecular Medicine

, Volume 20, Issue 1, pp 667–675 | Cite as

Stimulation of the α7 Nicotinic Acetylcholine Receptor Protects against Neuroinflammation after Tibia Fracture and Endotoxemia in Mice

  • Niccolò Terrando
  • Ting Yang
  • Jae Kyu Ryu
  • Phillip T. Newton
  • Claudia Monaco
  • Marc Feldmann
  • Daqing Ma
  • Katerina Akassoglou
  • Mervyn Maze
Open Access
Research Article

Abstract

Surgery and critical illness often associate with cognitive decline. Surgical trauma or infection can lead independently to learning and memory impairments via similar, but not identical, cellular signaling of the innate immune system that promotes neuroinflammation. In this study we explored the putative synergism between aseptic orthopedic surgery and infection, the latter reproduced by postoperative lipopolysaccharide (LPS) administration. We observed that surgery and LPS augmented systemic inflammation up to postoperative d 3 and this was associated with further neuroinflammation (CD11b and CD68 immunoreactivity) in the hippocampus in mice compared with those receiving surgery or LPS alone. Administration of a selective α7 subtype nicotinic acetylcholine receptor (α7 nAChR) agonist 2 h after LPS significantly improved neuroinflammation and hippocampal-dependent memory dysfunction. Modulation of nuclear factor-kappa B (NF-κB) activation in monocytes and regulation of the oxidative stress response through nicotinamide adenine dinucleotide phosphate (NADPH) signaling appear to be key targets in modulating this response. Overall, these results suggest that it may be conceivable to limit and possibly prevent postoperative complications, including cognitive decline and/or infections, through stimulation of the cholinergic antiinflammatory pathway.

Introduction

Acute illness and hospitalization is often accompanied by learning and memory impairments, especially among elderly patients, a steadily growing portion of the surgical and intensive care unit (ICU) populations (1). Postoperative cognitive dysfunction (POCD) associates with higher morbidity and mortality (even when propensity matched for comorbidities), including increase in functional disability and rates of admission to long-term care institutions; the presence of postoperative cognitive decline significantly increases the costs to healthcare (2). Although the mechanisms underlying changes in acute mental function remain unclear, multiple risk factors, in particular age, surgical procedures (including cardiac and orthopedic in particular) and infections, have been linked to the development of POCD (3,4). Neuroinflammation initiated by extra-central nervous system (CNS) surgical trauma, has been advanced as a key component in the pathogenesis of surgery-induced cognitive dysfunction; however, the mechanisms whereby neuroinflammation impairs behavior in the perioperative period remain unclear (5).

There is increasing evidence that the CNS can regulate immune and inflammatory processes (6). Soluble mediators from the periphery can exert multiple effects on the brain, contributing to “sickness behavior” and memory impairments (7). Preclinical models suggest a key role for the innate immune response, including release of systemic cytokines such as tumor necrosis factor α (TNF-α), interleukin (IL)-1β and high mobility group box 1 (HMGB-1) in contributing to neuroinflammation and cognitive decline (8, 9, 10). Direct neural pathways including cholinergic signaling via the vagus nerve and the α7 nicotinic acetylcholine receptor (α7 nAChR) regulate the acute and chronic inflammatory response (11). In surgery-induced inflammation, we reported that α7 nAChR signaling attenuates postoperative cognitive decline by modulating endothelia function at the blood-brain barrier (BBB) and preventing macrophage infiltration into the CNS (12).

In the present study, we sought to explore the effect of lipopolysaccharide (LPS), a surrogate for postoperative infection, on surgery-induced neuroinflammation and cognitive decline. Since postoperative complications, in particular infective and respiratory complications, have been significantly associated with prolonged postoperative cognitive decline (3), we combined our surgical model with endotoxemia to test the effects of a selective α7 nAChR agonist on cognitive function and neuroinflammation in this two-hit model. Herein, we demonstrate that postoperative LPS exposure prolongs the inflammatory response induced by the surgical procedure and that activation of endogenous inflammatory-resolving mechanisms via stimulation of the α7 nAChR signaling pathway attenuates the cognitive dysfunction.

Materials and Methods

Animals and Surgery

Wild-type male C57BL/6J mice (12 wks old) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). All animals were fed standard rodent chow and water ad libitum, and housed (< five mice/cage) in sawdust-lined cages in an air-conditioned environment with 12 h light-dark cycles. Seven days of acclimatization were allowed before starting any experiment. All animals were monitored on a daily basis for general body conditions. Experiments were conducted under the UK Home Office and IACUC, University of California (San Francisco, CA, USA) approved licenses.

Animals were anaesthetized with isoflurane at a minimum alveolar concentration (MAC) of 1.5 ± 0.2 (corresponding to an end-tidal concentration of 2.1% isoflurane) at 30% FiO2 and combined with buprenorphine (Buprenex, 0.1 mg/kg subcutaneously [s.c.]). An open tibial fracture was performed under aseptic conditions as described previously (13). A middle incision was performed on the left hind paw and a 0.38-mm pin was inserted into the intramedullary canal, the periosteum stripped and osteotomy performed. Drugs were diluted in 0.9% saline prior to use and injected as indicated. Mice were then allowed to recover from surgery and anesthesia and were subjected to an intraperitoneal (IP) injection of either vehicle (S-group) or LPS (S+LPS-group) derived from Escherichia coli endotoxin (0111:B4, 1 mg/kg) (InvivoGen, San Diego, CA, USA) at 24 h postoperatively. The α7 nAChR agonist PHA 568487 (0.4 mg/kg) (12) (Tocris Bioscience, Ellisville, MO, USA) (S+LPS+PHA-group) was administered IP 2 h following LPS administration when sickness became noticeable in behavior.

Cytokine Measurement

Blood was sampled transcardially after thoracotomy under terminal anesthesia 3 and 7 d in separate cohorts and centrifuged at 2,000g for 7 min at 4°C. Blood samples taken from animals without any interventions served as controls. Plasma samples were stored at −20°C for further analysis. Plasma cytokines were measured by enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s instruction (Biosource, Camarillo, CA, USA). The sensitivities of the assays were <7 pg/mL for IL-1β, and <3 pg/mL for IL-6.

Immunohistochemistry (IHC)

Mice were deeply anesthetized with isoflurane and perfused transcardially with ice-cold heparinized 0.1mol/L phosphate buffer solution (PBS) followed by 4% paraformaldehyde (PFA) in 0.1 mol/L PBS at pH 7.4 (VWR International, East Grinstead, UK). The brains were harvested and postfixed in 4% PFA at 4°C overnight and cryoprotected in 15% sucrose for 24 h (VWR International) and then 30% sucrose for a further 48 h. Brain tissue was then embedded in OCT (VWR International), coronal sections were cut at 25 µm and mounted on Superfrost plus slides (Menzel-Glaser, Braunschweig, Germany). The sections were quenched for 30 min with 0.3% hydrogen peroxide in 70% methanol and blocked in 3% normal goat serum for 1 h, then incubated in rat anti-CD11b (1:200, low endotoxin, clone M1/70.15, Serotec, Oxford, UK) overnight at 4°C. A goat anti-rat secondary antibody (1:200, Chemicon International, CA, USA) was applied for 1 h, the staining was revealed by the ABC reagent (standard Vectastain ABC Elite Kit, Vector Labs, Cambridge, UK) and 3,3′-diaminobenzidine (DAB) (Vector Labs). To label monocytes/macrophages, sections were incubated in a rabbit anti-CD68 (1:250, Abcam, Cambridge, UK) for 24 h at 4°C followed by a goat anti-rabbit Cy3 conjugated secondary antibody (1:500, Chemicon International, Temecula, CA, USA) for 1 h at room temperature in dark. A negative control omitting the primary antibody was performed in all experiments. Photomicrographs were acquired with a digital microscope (Axiocam, Carl Zeiss, Thornwood, NY, USA) and immunoreactivity was calculated using a 0.4 mm2 frame in three coronal hippocampal regions. Image quantification was analyzed with ImageJ software (NIH, Bethesda, MD, USA; https://doi.org/imagej.nih.gov/ij/) as described previously (12).

Bone Marrow-Derived Macrophages (BMDMs)

Briefly, bone marrow (BM) was isolated from the tibia and femur of 10-wk-old mice. BM cells were cultured in RPMI 1640 (Invitrogen [Thermo Fisher Scientific Inc., Waltham, MA, USA]) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (Invitrogen [Thermo Fisher Scientific]), 1% penicillin-streptomycin (Invitrogen [Thermo Fisher Scientific]), and 10 ng/mL murine M-CSF (eBioscience, San Diego, CA, USA). On d 6, adherent BMDMs were harvested from plates by the addition of PBS containing 5 mmol/L ethylenediaminetetracetic acid for experiments. BMDMs were plated and cultured with 1% fetal bovine serum in RPMI 1640 overnight in Nunc plates. Cells were preincubated with PHA 568487 (10 µg/mL) for 30 min followed by mouse LPS (100 ng/mL) stimulation for 2 h. The cells were then fixed with 4% paraformaldehyde for 15 min at room temperature, rinsed in PBS and incubated with blocking buffer (PBS containing 5% normal goat serum and 0.3% Triton X-100) for 60 min. Cells were stained with anti-phospho-NF-κB p65 (1:200) (Cell Signaling Technology, Danvers, MA, USA) for 24 h at 4°C. Cells were washed in PBS and incubated with anti-rabbit Cy3-conjugated secondary antibody (1:200) (Jackson ImmunoResearch, West Grove, PA, USA) for 1.5 h at room temperature in the dark. After washing with PBS, coverslips were mounted using ProLong Gold antifade reagent (Invitrogen [Thermo Fisher Scientific]). Five representative images per well were taken using an Axioplan II epifluorescence microscope (Carl Zeiss) with a dry Plan-Neofluar 40 0.75 NA objective and an AxiocamHRc CCD camera. Images were acquired and analyzed with AxioVision image analysis software. Quantification was determined as the proportion of total cells exhibiting nuclear phospho-NF-κB p65. All experiments were repeated three times.

Another batch of BMDMs were stimulated with LPS for 24 h. Cells were then incubated in DPBS for 10 min at 37°C and pipetted gently multiple times to obtain the cell suspension. Nicotinamide adenine dinucleotide phosphate-mediated (NADPH-mediated) superoxide generation was detected by AutoLumat LB953 Multi-Tube Luminometer (Berthold Technologies, Bad Wildbad, Germany) as described previously (14). NADPH (100 µmol/L, Sigma-Aldrich) and lucigenin (5 µmol/L, Sigma-Aldrich) were added to the cell suspension, superoxide level was determined by measuring lucigenin chemiluminescence every 3 s for 3 min.

In Vitro Chondrogenic Differentiation Model

The nontransformed mesenchymal rat chondrogenic cell-line RCJ3.1C5.18 (C5.18) was obtained from Anna Spagnoli (15). C5.18 cells were maintained in minimal essential medium containing 15% FBS with 10−7 mol/L dexamethasone (16). Cells were seeded in maintenance medium, and, once confluent, subsequently supplemented with 50 µg/mL ascorbic acid (Sigma-Aldrich, St. Louis, MO, USA; A5960) and 1 mmol/L β-glycerophosphate (BGP) (Sigma-Aldrich, G9422) to stimulate chondrogenic differentiation, in the presence of 10 µg/mL PHA 568487 or PBS vehicle. Alcian blue staining and quantification was performed as described previously (17). Quantification of colonies was performed using ImageJ software (NIH) by setting color and size thresholds. For all treatment groups, n = 6 wells.

Contextual Fear Conditioning

Behavior was performed in a dedicated fear-conditioning chamber (Med Associates Inc., St Albans, VT, USA). Mice are trained to associate an environment (context) with a conditional stimulus (tone) and an unconditional stimulus (foot shock). Training paradigm was performed as described previously (8): tone duration 20 s, level 75 dB; shock duration 2 s, and intensity 0.75 mAmp. Mice were trained before surgery and all mice received the same handling regardless of the final group allocation. During training, an initial exploratory phase (100 s) was followed by two trials separated by a 100-s intertrial interval. Trials consisted of a 20 s auditory cue (75–80 dB, 5k Hz, conditional stimulus) followed by a 2-s foot shock (0.75 mAmp, unconditional stimulus). Contextual assessment was performed 72 h after surgery in the same chamber but with no cues (tone or shock). Freezing behavior, excluding breathing and movement of vibrissae, was automatically scored for 270 s by the video tracking software. Freezing scores for each subject were expressed as a percentage for each portion of the test. Memory for the context (contextual memory) for each subject was obtained by subtracting the percent freezing in the novel environment from that in the context.

General locomotion activity was measured after contextual assessment using an automated photobeam activity system (Aditech, Fjärås, Sweden) with a 5 min exploration period. All assessments were performed in a blinded fashion.

Data Analysis

Statistical analyses were performed using GraphPad Prism version 5.0d (GraphPad Software, San Diego, CA, USA). The results are expressed as mean ± SEM. Data were analyzed with analysis of variance followed by Newman-Keuls post hoc test wherever appropriate. A P < 0.05 was considered to be a statistical significance.

Results

Cholinergic Agonist Improves LPS-Exacerbated Cognitive Decline

To understand the contribution of surgical trauma and infection on memory function, we administered LPS systemically 24 h after orthopedic surgery to recreate a clinical scenario of postoperative wound infection (Figure 1A). To assess hippocampal-dependent memory function, we trained mice 30 min before surgery using trace fear conditioning and performed contextual assessment on postoperative d 3 (8,9). Mice exposed to surgery and postoperative LPS exhibited a significant reduction in cognitive function (freezing S+LPS-group 22.86 ± 2.9 versus C-group 66.88 ± 2.5, P < 0.01) when compared with either surgical or LPS-exposed animals only (freezing S-group 38.25 ± 4.9 versus LPS-group 36.88 ± 4.2, Figure 1B, P < 0.05). To attempt to ameliorate this cognitive impairment caused by surgery and LPS, we injected intraperitoneally a selective α7 nAChR agonist (PHA 568487) 2 h following endotoxemia and tested the contextual memory on d 3. Treatment with PHA 568487 significantly improved the freezing behavior attenuating the memory dysfunction caused by the two-hit provocation (freezing S+LPS+PHA-group 53.57 ± 5.5, P < 0.01). To exclude locomotor impairments or general immobility due to sickness behavior, mice were tested in an open field and no significant changes were observed between groups (Figure 1C). Together, these results suggest a use for cholinergic agonists in limiting adverse cognitive outcome caused by trauma and endotoxemia.
Figure 1

Cholinergic stimulation improves cognitive outcome after surgery and LPS administration. (A) Mice were operated on within 30 min after training. At 24 h the S+LPS-group received 1 mg/kg LPS and a bolus injection of PHA 568487 or saline after 2 h. (B) Contextual fear response, as measured by freezing behavior, is impaired in animals receiving surgery followed by LPS exposure as compared with naïve (saline injected) or surgery groups. Administration of a selective α7 nAChR agonist (PHA) significantly improved the cognitive abnormality. (C) Open field was performed after TFC to measure general locomotor activity for a duration of 5 min; no differences in general activity were observed among groups. Data are expressed as mean ± SEM, n = 10. (*P < 0.05 versus C; **P < 0.01 versus C; #P < 0.05 versus S; &P < 0.05 versus LPS; ^^P < 0.01 versus S+LPS). C, control; S, surgery; PHA, PHA 568487; TFC, trace fear conditioning; OF, open field.

α7 nAChR Inhibits Hippocampal CD11b/CD68 Activation

To understand how PHA 568487 protected from further memory decline, we assessed neuroinflammation in the hippocampus on postoperative d 3 and 7. We used CD11b to visualize activated microglia and recruited macrophages (antigenically indistinguishable) and CD68 to further highlight the process of active phagocytosis in the hippocampus (18). Densitometry of CD11b immunostaining revealed significantly higher immunoreactivity with hypertrophy of cell bodies and clumping of the ramifications, characteristic of activation, following the combination of surgery with LPS as compared with surgery or LPS only (P < 0.05, Figure 2). Both surgery and LPS activated immunocompetent cells in the CNS, including CD68+ cells, yet the combination of these challenges significantly enhanced stimulated microglia/monocytes in the hippocampus after 3 d and this persisted for up to postoperative d 7 (P < 0.01, Figure 3).
Figure 2

PHA 568487 effects on CD11b activation following surgery and LPS. Hippocampi were harvested at 3 and 7 d after surgery/LPS administration and stained with anti-CD11b. Photomicrographs show CA1 of control animals (C), surgery (S), lipopolysaccharide (LPS), surgery with postoperative LPS (S+LPS) and in combination with a bolus dose of a selective α7 nAChR agonist (S+LPS+PHA) at 3 d. Higher CD11b immunoreactivity was observed after surgery and LPS exposure at both 3 and 7 d (P < 0.01, P < 0.05 respectively). Significant hypertrophy of the cell bodies and loss of pseudopodia occurred in LPS-treated mice after orthopedic surgery; this was attenuated by administration of PHA 568487 2 h after LPS onset (P < 0.01 versus S+LPS). Reactive microglia/monocytes were present up to d 7 in the S+LPS group and returned to baseline in the other treatment groups. Data are expressed as mean ± SEM and compared by one-way ANOVA and Student-Newman-Keuls method, n = 4 (**P < 0.01 versus C; #P < 0.05 versus S; ##P < 0.01 versus S; &&P < 0.05 versus LPS; ^P < 0.05 versus S+LPS; ^^P> 0.01 versus S+LPS). Scale bar, 50 µm. C, control; S, surgery; PHA, PHA 568487.

Figure 3

Cholinergic agonist reduces reactive macrophages/microglia in the hippocampus after surgery and LPS. Hippocampi were harvested at 3 and 7 d after surgery/LPS administration and stained with anti-CD68. Epifluorescence shows enhanced immunoreactivity 3 d after surgery (S) and lipopolysaccharide (LPS) exposure. Postoperative infection (S+LPS) further increased the number of CD68+ cells, persisting up to d 7. Administration of a single bolus dose of a selective α7 nAChR agonist (PHA 568487) significantly reduced levels of CD68+ immunoreactivity, returning to baseline at 7 d. Nuclei are counterstained with DAPI. Data are expressed as mean ± SEM and compared by one-way ANOVA and Student-Newman-Keuls method, n = 4 (**P < 0.01 versus C; #P < 0.05 versus S; ##P < 0.01 versus S; &&P < 0.01 versus LPS; ^^P < 0.01 versus S+LPS). Scale bar, 30 µm. C, control, S, surgery; PHA, PHA 568487.

Monocytes and microglia widely express α7 nAChR (19). Notably, treatment with PHA 568487 significantly reduced the activation of CD68+ and CD11b+ cells in the hippocampus at d 3 (P < 0.01 respectively) and prevented its upregulation at d 7 (P < 0.01 and P < 0.05 respectively) in surgical mice following LPS administration, suggesting that α7 nAChR negatively regulates neuroinflammation and microglia/macrophage activation (Figures 2, 3).

Systemic Antiinflammatory Effects after Postoperative LPS Administration

Prior work implicated a role for the systemic inflammatory milieu in modulating neuroinflammation and cognitive function (20). Transient changes in proinflammatory cytokines are observed after surgery and appear to contribute to the pathogenesis of postoperative cognitive decline. Systemic levels of IL-1β and IL-6 were increased significantly up to d 3 combining surgery and LPS exposure. Compared to surgery or LPS alone, the double hit (S+LPS) group had a significant increase in both IL-1β (43.13 ± 4.5 pg/mL, S+LPS versus S, P < 0.01, Figure 4A) and IL-6 (283 ± 31.16pg/mL, S+LPS versus S, P < 0.01, Figure 4B) after 3 d, with levels returning to baseline by d 7.
Figure 4

Infection prolongs systemic and neuroinflammatory response after surgery. Mice were injected with LPS 24 h after orthopedic surgery. Plasma levels of IL-1β and IL-6 were measured by ELISA in plasma and hippocampal tissue. (A) At 3 d following surgery, LPS treated animals had a sustained elevation of IL-1β in plasma. (B) Similarly, systemic levels of IL-6 were also upregulated at 3 d, returning to baseline by 7 d. Data are expressed as mean ± SEM and compared by one-way ANOVA and Student-Newman-Keuls method, n = 4 (**P < 0.01 versus C; #P < 0.05 versus S; ##P < 0.01 versus S; &&P < 0.01 versus LPS; ^^P < 0.01 versus S+LPS). C, control; S, surgery.

Administration of PHA 568487 significantly attenuated the proinflammatory response reducing levels of both IL-1β (7.6 ± 2.63pg/mL, S+LPS versus S+LPS+PHA, P < 0.01, Figure 4A) and IL-6 (109.1 ± 11.53pg/mL, S+LPS versus S+LPS+PHA, P < 0.05, Figure 4B).

Effects of α7 nAChR Stimulation on Bone Marrow-Derived Macrophages and Chondrocytes In Vitro

Macrophage activity is required to mediate surgery-induced neuroinflammation (12,21) and bone marrow-derived cells are integral to a functioning inflammatory reflex (22). To better understand the antiinflammatory effects of cholinergic stimulation, we incubated bone marrow-derived macrophages (BMDMs) with the selective α7 cholinergic receptor agonist (PHA 568487, 10 µg/mL) and LPS (100 ng/mL) to measure phosphorylation and nuclear translocation of the p65 subunit of NF-κB. Consistent with previous studies, α7 nAChR signaling prevented NF-κB activation in vitro (Figure 5A). Furthermore, cholinergic stimulation also prevented LPS-induced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase production in vitro, restoring superoxide levels to baseline (P < 0.001, Figure 5B). This suggests that α7 nAChR stimulation exerts antiinflammatory and antioxidative effects on macrophages, thus preventing further proinflammatory cytokines release.
Figure 5

LPS-induced NF-κB and NADPH activation in BMDMs is blocked by PHA 568487. (A) Cultured BMDMs were stimulated with LPS (100 ng/mL) for 2 h and immunostained for nuclear phosphorylated NF-κB subunit p65. Preincubation with PHA 568487 (10 µg/mL) for 30 min significantly reduced activation and nuclear translocation of p65 (LPS+PHA). NF-κB activation was undetectable in unexposed cells (medium) or in cells exposed to PHA 568487 (PHA). (B) NADPH oxidase mediated superoxide generation from BMDMs was measured by chemiluminescence method. LPS stimulation at 10 ng/mL for 24 h significantly increased superoxide generation from BMDMs (***P < 0.001 versus C), which was abolished by preincubation of PHA (&&&p< 0.001 versus LPS). PHA perse did not significantly affect superoxide generation in nonstimulated BMDMs. Data are expressed as mean ± SEM and compared by one-way ANOVA and Bonferroni posthoc, n = 6. C, control; PHA, PHA 568487

We next assessed if PHA 568487 would affect the rate of bone healing. Bone repair occurs through a process resembling endochondral bone formation, which begins with a cartilaginous intermediate (23). We differentiated a chondrogenic cell line in the presence of PHA 568487 or vehicle and found that PHA 568487 reduced the rate of deposition of cartilaginous extracellular matrix (based on Alcian blue staining of glycosaminoglycans) (Figure 6A). After 7 d in the presence of PHA 568487 there was a reduction in the number of Alcian blue-positive colonies (62% of vehicle, p = 0.0119, n = 6 wells). This was confirmed by assessing total glycosaminoglycan labeling, which was greatest after 12 d of differentiation when it reached a 64% reduction versus the vehicle (Figure 6B).
Figure 6

PHA 568487 impairs cartilage matrix formation. (A) C5.18 cells were differentiated in the presence or absence of 10 µg/mL PHA, and fixed at two time points. (B) Alcian blue staining was performed on whole wells, which were leached and quantified. Data are expressed as mean ± SEM and compared by t test, n = 6. C, control; PHA, PHA 568487.

Discussion

In this study we demonstrated that postoperative complications such as infection prolong the neuroinflammatory response after surgical trauma and worsen cognitive decline. Stimulation of the cholinergic antiinflammatory pathway reduces the innate immune response offering a novel strategy to prevent cognitive decline following postoperative endotoxemia.

Nonresolving inflammation is recognized as a major component of several disease states (24). Aseptic injury activates the innate immune system by releasing damage-associated molecular patterns (DAMPs) and cytokines, which interfere with the brain microenvironment and may ultimately lead to cognitive decline. In this study, we combined the effects of aseptic injury with postoperative endotoxemia using LPS as a key component of the gram-negative bacteria outer membrane and a classic initiator of the inflammatory cascade. Although LPS does not faithfully reproduce the complexity of in-hospital infections, especially due to the higher incidence of polymicrobial and virulent strains of methicillin-resistant S. aureus (MRSA) (25), gram-negative bacteria commonly associate with orthopedic blast injuries (26). There is also opportunity for LPS to bind to orthopedic implants and biomaterials, potentially triggering a systemic inflammatory reaction and prompting joint revision surgery (27), thus these results may be applicable to different perioperative settings.

Augmented levels of systemic cytokines can account for many of the physiological and behavioral changes, both in humans and animals, and are dysregulated in multiple disease states. The effects of additive systemic inflammatory insults in this mouse model are evident, both in the neuroinflammatory response and hippocampal-dependent memory function assessed by contextual fear conditioning. Systemic inflammation and release of proinflammatory cytokines including IL-1β and IL-6 after surgery can prime the CNS, causing microglia to become more susceptible to the second hit (28). Both microglia priming and synaptic loss have been related to acute memory dysfunction and neurodegenerative processes in the presence of a deleterious systemic proinflammatory milieu (29). Similar changes in CNS function, including synaptic plasticity and altered neurogenesis, have been observed during aging, with specific age-related systemic chemokines contributing to the overall processes of cognitive decline (20). Even though cognitive impairments are observed in patients at all ages, only the elderly are at higher risk for POCD (30) and the priming of the immune system in the aged may be responsible for this higher susceptibility and more severe prognosis.

The mechanisms whereby cytokines and other proinflammatory mediators prime the CNS after surgery are not fully understood. LPS does not cross the BBB (31) but has the ability to disrupt immune-endothelial interactions, thus allowing proinflammatory immune cells to enter the CNS (32). Recently, we reported a key role for macrophage infiltration in the hippocampus after orthopedic surgery through a disrupted BBB (12,21), suggesting both cytokines and LPS may access the brain directly following the initial trauma. Remarkably, similar effects on cognitive decline were reported using a subclinical dose of LPS administered systemically before surgery, demonstrating that the reversed combination of these two hits also impaired hippocampal memory consolidation (33).

Proinflammatory cytokines also can stimulate afferent C-fibers to open the blood-spinal cord barrier allowing macrophages, T-cells and other soluble factors to reach the brain via the spinal cord (34,35). Interestingly, patients undergoing total hip arthroplasty display elevated proinflammatory cytokines in the cerebrospinal fluid (CSF) in the postoperative period and this could contribute to worse cognitive outcome (36). Biomarkers of acute neuroinflammation and Alzheimer’s disease (AD) including IL-6, TNF-α, S100β and tau are similarly regulated in the CSF of otherwise healthy patients following surgery under general anesthesia (37). Serum levels of IL-6 also have been correlated with the diagnosis of periprosthetic infection after arthroplasty (38). In our animal model, the systemic levels of IL-6 also were significantly elevated after surgery and LPS challenge, indicating a possible role for biomarkers in predicting poorer prognosis including adverse cognitive outcome. Cholinergic stimulation limits systemic proinflammatory cytokine release which may stabilize endothelial function at the BBB and thereby protect the brain from prolonged neuroinflammation and cognitive dysfunction (12,39).

Apart from the cellular and humoral mediation in immune-to-brain signaling, neural regulation of inflammatory processes occurs in many disorders (40). In this study, we tested the effects of a selective α7 nAChR agonist on the nonresolving inflammation following surgery and LPS. Systemic administration of PHA 568487 after LPS exposure reduced proinflammatory cytokines and neuroinflammation, significantly attenuating CD11b+/CD68+ cells in the hippocampus and improving cognitive function. It is possible that the antiinflammatory effects of PHA 568487 are not limited to NF-κB and oxidative stress signaling in bone marrow-derived monocytes as we report in this study (Figure 7). α7 nAChR signaling was recently shown to modulate inflammasome activity, affecting the proteolytic maturation of key cytokines such as IL-1β, IL-18 and HMGB-1 (41). Notably, both IL-1β and HMGB-1 have been related to cognitive decline in models of surgery (9,10,42), infection (43) and sepsis (44), suggesting targeting these molecules may protect against cognitive decline. Cholinergic agonists, acting on both α7 and α4β2 subunits, can also alter synaptic plasticity, enhancing neuronal transmission and improving cognitive function (45). Notably, α7 nAChR also is functionally expressed on nonexcitable cells, including the endothelium, keratinocytes and chondrocytes (46). Using a chondrogenic cell line model, we found PHA 568487 impaired cartilage matrix formation, which may indicate a disruption of the bone healing process after an orthopedic trauma. Prolonged nicotine exposure was earlier shown to delay skeletal growth through α7 nAChR-dependent signaling (47). These findings warrant further studies in vivo to ascertain the potential benefits of cholinergic modulation in the perioperative setting.
Figure 7

Working model. Peripheral injury leads to a systemic inflammatory response and release of danger-associated molecular patterns (DAMPs) in the circulation causing neuroinflammation and subsequent cognitive decline. Postoperative infection elicits a secondary hit that exacerbates the proinflammatory milieu and CNS dysfunction. Stimulation of the cholinergic antiinflammatory signaling pathway via selective α7 nAChR improves cognitive decline though modulation of NF-κB and oxidative stress activity on monocytes, thus attenuating neuroinflammation and dampening the systemic proinflammatory milieu.

Recently, a role for the vagus nerve in regulating proresolving mediators, such as resolvin D1, has been proposed and this provides a novel understanding for the neuronal control of resolution (48). Interestingly, administration of aspirintriggered resolvin D1 after surgery protected the brain from synaptic dysfunction and cognitive decline, suggesting that stimulation of endogenous signaling pathways may represent an effective way to prevent and treat inflammatory conditions by promoting resolution (14,49). Of relevance to POCD, aberrant inflammation and impaired proresolving mediator levels have been associated with the process of physiological aging (50), and may provide novel approaches to biomarkers discovery in aging patients at risk for cognitive decline.

Conclusion

In conclusion, this study provides novel insights into the impact of aseptic trauma and LPS on brain function. Through stimulation of the cholinergic antiinflammatory pathway, we may offer a novel strategy to limit POCD and prevent adverse neuroinflammatory complications. Excessive inflammation and oxidative stress represent novel targets for resolving neuroinflammation in the perioperative period.

Disclosure

The authors declare that they have no competing interests as defined by Molecular Medicine, or other interests that might be perceived to influence the results and discussion reported in this paper.

Notes

Acknowledgments

This work was supported by R01 GM104194 (M Maze), the Anesthesia Department, UCSF (M Maze), a research grant program of the European Society of Anaesthesiology and Karolinska Institutet Funds (N Terrando), NIH grants R01 NS052189 and R21 NS082976 (K Akassoglou) and the Mathilda and Terence Kennedy Institute of Rheumatology Trust (M Feldmann, C Monaco).

References

  1. 1.
    Ehlenbach WJ, et al. (2010) Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA. 303:763–70.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Saczynski JS, et al. (2012) Cognitive trajectories after postoperative delirium. N. Engl. J. Med. 367:30–9.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Moller JT, et al. (1998) Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet. 351:857–61.CrossRefGoogle Scholar
  4. 4.
    Terrando N, et al. (2011) Perioperative cognitive decline in the aging population. Mayo Clin. Proc. 86:885–93.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Riedel B, Browne K, and Silbert B. (2014) Cerebral protection: inflammation, endothelial dysfunction, and postoperative cognitive dysfunction. Curr. Opin. Anaesthesiol 27:89–97.CrossRefPubMedGoogle Scholar
  6. 6.
    Tracey KJ. (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117:289–96.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Dantzer R, et al. (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:46–56.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Terrando N, et al. (2010) Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc. Natl. Acad. Sci. U. S. A. 107:20518–22.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Cibelli M, et al. (2010) Role of interleukin-1beta in postoperative cognitive dysfunction. Ann. Neurol. 68:360–8.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Vacas S, et al. (2014) High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages. Anesthesiology. 120:1160–7.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Olofsson PS, et al. (2012) Rethinking inflammation: neural circuits in the regulation of immunity. Immunol. Rev. 248:188–204.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Terrando N, et al. (2011) Resolving postoperative neuroinflammation and cognitive decline. Ann. Neurol. 70:986–95.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Harry LE, et al. (2008) Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J. Orthop. Res. 26:1238–44.CrossRefPubMedGoogle Scholar
  14. 14.
    Terrando N, et al. (2013) Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. FASEB J. 27:3564–71.CrossRefPubMedGoogle Scholar
  15. 15.
    Spagnoli A, et al. (2001) Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. relationship to differentiation stage. J. Biol. Chem. 276:5533–40.CrossRefPubMedGoogle Scholar
  16. 16.
    Lunstrum GP, et al. (1999) Chondrocyte differentiation in a rat mesenchymal cell line. J. Histochem. Cytochem. 47:1–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Newton PT, et al. (2012) Chondrogenic ATDC5 cells: an optimised model for rapid and physiological matrix mineralisation. Int. J. Mol. Med. 30:1187–93.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Perego C, Fumagalli S, and De Simoni MG. (2011) Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J. Neuroinflammation. 8:174.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Wang H, et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003. 421:384–8.Google Scholar
  20. 20.
    Villeda SA, et al. (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 477:90–4.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Degos V, et al. (2013) Depletion of bone marrowderived macrophages perturbs the innate immune response to surgery and reduces postoperative memory dysfunction. Anesthesiology. 118:527–36.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Olofsson PS, et al. (2012) α7 nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Mol. Med. 18:539–43.CrossRefPubMedGoogle Scholar
  23. 23.
    Ford JL, Robinson DE, Scammell BE. (2004) Endochondral ossification in fracture callus during long bone repair: the localisation of ‘cavity-lining cells’ within the cartilage. J. Orthop. Res. 22:368–75.CrossRefPubMedGoogle Scholar
  24. 24.
    Nathan C, Ding A. (2010) Nonresolving inflammation. Cell. 140:871–82.CrossRefGoogle Scholar
  25. 25.
    Bernthal NM, et al. (2010) A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One. 5:e12580.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Mody RM, et al. (2009) Infectious complications of damage control orthopedics in war trauma. J. Trauma. 67:758–61.CrossRefPubMedGoogle Scholar
  27. 27.
    Ragab AA, et al. (1999) Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J. Orthop. Res. 17:803–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Perry VH, Holmes C. (2014) Microglial priming in neurodegenerative disease. Nat. Rev. Neurol. 10:217–24.CrossRefPubMedGoogle Scholar
  29. 29.
    Cunningham C, et al. (2009) Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol. Psychiatry. 65:304–12.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Monk TG, et al. (2008) Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 108:18–30.CrossRefPubMedGoogle Scholar
  31. 31.
    Gyoneva S, et al. (2014) Systemic inflammation regulates microglial responses to tissue damage in vivo. Glia. 62:1345–60.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Ramirez SH, et al. (2012) Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions. J. Neurosci. 32:4004–16.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Fidalgo AR, et al. (2011) Systemic inflammation enhances surgery-induced cognitive dysfunction in mice. Neurosci. Lett. 498:63–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Beggs S, et al. (2010) Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier. Mol. Pain. 6:74.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Arima Y, et al. (2012) Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell. 148:447–57.CrossRefGoogle Scholar
  36. 36.
    Buvanendran A, et al. (2006) Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology. 104:403–10.CrossRefGoogle Scholar
  37. 37.
    Tang JX, et al. (2011) Human Alzheimer and inflammation biomarkers after anesthesia and surgery. Anesthesiology. 115:727–32.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Di Cesare PE, et al. (2005) Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. J. Bone Joint Surg. Am. 87:1921–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Krafft PR, et al. (2013) PHA-543613 preserves blood-brain barrier integrity after intracerebral hemorrhage in mice. Stroke. 44:1743–7.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Andersson U, Tracey KJ. (2012) Neural reflexes in inflammation and immunity. J. Exp. Med. 209:1057–68.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Lu B, et al. (2014) Alpha 7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release. Mol. Med. 20:350–8.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    He HJ, et al. (2012) Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats. CNS Neurosci. Ther. 18:994–1002.CrossRefPubMedGoogle Scholar
  43. 43.
    Terrando N, et al. (2010) The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit. Care. 14:R88.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Chavan SS, et al. (2012) HMGB1 mediates cognitive impairment in sepsis survivors. Mol. Med. 18:930–7.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Couey JJ, et al. (2007) Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron. 54:73–87.CrossRefPubMedGoogle Scholar
  46. 46.
    Sharma G, Vijayaraghavan S. (2002) Nicotinic receptor signaling in nonexcitable cells. J. Neurobiol. 53:524–34.CrossRefPubMedGoogle Scholar
  47. 47.
    Kawakita A, et al. (2008) Nicotine acts on growth plate chondrocytes to delay skeletal growth through the alpha7 neuronal nicotinic acetylcholine receptor. PLoS One. 3:e3945.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Mirakaj V, et al. (2014) Vagus nerve controls resolution and pro-resolving mediators of inflammation. J. Exp. Med. 211:1037–48.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Serhan CN, et al. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21:325–32.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Arnardottir HH, et al. (2014) Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nanoproresolving medicines. J. Immunol. 193:4235–44.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Author(s) 2014

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  • Niccolò Terrando
    • 1
    • 2
  • Ting Yang
    • 1
    • 2
  • Jae Kyu Ryu
    • 3
  • Phillip T. Newton
    • 1
    • 4
  • Claudia Monaco
    • 5
  • Marc Feldmann
    • 5
  • Daqing Ma
    • 6
  • Katerina Akassoglou
    • 3
    • 7
  • Mervyn Maze
    • 2
  1. 1.Department of Physiology and PharmacologyKarolinska InstituteStockholmSweden
  2. 2.Department of Anesthesia and Perioperative CareUCSF Medical CenterSan FranciscoUSA
  3. 3.Gladstone Institute of Neurological DiseaseUniversity of California San FranciscoSan FranciscoUSA
  4. 4.Department of Women’s and Children’s HealthAstrid Lindgren Children’s Hospital, Karolinska University HospitalStockholmSweden
  5. 5.Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal SciencesUniversity of OxfordLondonUK
  6. 6.Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of MedicineImperial College London, Chelsea & Westminster HospitalLondonUK
  7. 7.Department of NeurologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations